Registered entities
ADAPTIMMUNE LLC
Reg. No. 274919915United States
Adaptimmune Limited
Reg. No. 6456741United Kingdom
ADAPTIMMUNE THERAPEUTICS PLC
Reg. No. (44)1235430000Belgium
Innovation
113 patent families (42 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 6,797 times.
| Year | Filings |
|---|---|
| 2014 | 10 |
| 2015 | 10 |
| 2016 | 10 |
| 2017 | 53 |
| 2018 | 46 |
| 2019 | 29 |
| 2020 | 21 |
| 2021 | 58 |
| 2022 | 34 |
| 2023 | 32 |
| 2024 | 17 |
| 2025 | 17 |
Social engagement
Social engagement: 54.6K social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
19 investors on record; lead investors include New Enterprise Associates; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 53% |
| Private equity | 4 | 21% |
| Accelerator & incubator | 1 | 5% |
| Other / undisclosed | 4 | 21% |